The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126236631 12623663 1 I 20160606 20160701 20160804 20160804 EXP IT-MINISAL02-365631 IT-TEVA-674575ACC TEVA 92.25 YR M Y 0.00000 20160805 MD IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126236631 12623663 1 PS ZOLPIDEM TARTRATE. ZOLPIDEM TARTRATE 1 Oral 1 DOSAGE FORMS DAILY; U U 76410 1 DF
126236631 12623663 2 SS TRITTICO - 50 MG COMPRESSE RIVESTITE CON FILM TRAZODONE HYDROCHLORIDE 1 Oral DAILY U U 0
126236631 12623663 3 C CARDIRENE - 75 MG POLVERE PER SOLUZIONE ORALE ASPIRIN DL-LYSINE 1 U 0
126236631 12623663 4 C SELG - POLVERE PER SOLUZIONE ORALE 2 U 0
126236631 12623663 5 C LUVION - 50 MG COMPRESSE 2 U 0
126236631 12623663 6 C MINITRAN - 5 MG/24 ORE CEROTTI TRANSDERMICI 2 U 0
126236631 12623663 7 C COUMADIN WARFARIN SODIUM 1 U 0
126236631 12623663 8 C CLEXANE - 2000 U.I. AXA/0,2 ML SOLUZIONE INIETTABILE 2 U 0
126236631 12623663 9 C DIBASE - 10.000 UI/ML GOCCE ORALI SOLUZIONE 2 U 0
126236631 12623663 10 C CALCIUM CARBONATE. CALCIUM CARBONATE 1 U 0
126236631 12623663 11 C FUROSEMIDE. FUROSEMIDE 1 U 0
126236631 12623663 12 C RAMIPRIL. RAMIPRIL 1 U 0
126236631 12623663 13 C LANSOPRAZOLE. LANSOPRAZOLE 1 U 0
126236631 12623663 14 C FINASTERIDE. FINASTERIDE 1 U 0
126236631 12623663 15 C BISOPROLOL HEMIFUMARATE BISOPROLOL FUMARATE 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126236631 12623663 1 Product used for unknown indication
126236631 12623663 2 Product used for unknown indication
126236631 12623663 3 Product used for unknown indication
126236631 12623663 4 Product used for unknown indication
126236631 12623663 5 Product used for unknown indication
126236631 12623663 6 Product used for unknown indication
126236631 12623663 7 Product used for unknown indication
126236631 12623663 8 Product used for unknown indication
126236631 12623663 9 Product used for unknown indication
126236631 12623663 10 Product used for unknown indication
126236631 12623663 11 Product used for unknown indication
126236631 12623663 12 Product used for unknown indication
126236631 12623663 13 Product used for unknown indication
126236631 12623663 14 Product used for unknown indication
126236631 12623663 15 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126236631 12623663 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126236631 12623663 Confusional state
126236631 12623663 Dysarthria
126236631 12623663 Sopor

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126236631 12623663 1 20160101 20160628 0
126236631 12623663 2 20160101 20160606 0